User profiles for Aliya Khan
Aliya A. KhanProfessor of Clinical Medicine, McMaster University Verified email at mcmaster.ca Cited by 23385 |
Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy
…, ES Siris, N Binkley, MK Beard, A Khan… - The Journal of …, 2005 - academic.oup.com
Purpose: To evaluate serum 25-hydroxyvitamin D [25(OH)D] concentrations and factors related
to vitamin D inadequacy in postmenopausal North American women receiving therapy to …
to vitamin D inadequacy in postmenopausal North American women receiving therapy to …
Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus
AA Khan, A Morrison, DA Hanley… - Journal of Bone and …, 2015 - academic.oup.com
This work provides a systematic review of the literature from January 2003 to April 2014
pertaining to the incidence, pathophysiology, diagnosis, and treatment of osteonecrosis of the …
pertaining to the incidence, pathophysiology, diagnosis, and treatment of osteonecrosis of the …
Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop
JP Bilezikian, AA Khan, JT Potts Jr… - The Journal of …, 2009 - academic.oup.com
Objective: Asymptomatic primary hyperparathyroidism (PHPT) is a common clinical problem.
The purpose of this report is to guide the use of diagnostics and management for this …
The purpose of this report is to guide the use of diagnostics and management for this …
Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target‐organ involvement, treatment, and challenges for future research
JP Bilezikian, A Khan, JT Potts Jr… - Journal of Bone and …, 2011 - academic.oup.com
Recent advances in understanding the epidemiology, genetics, diagnosis, clinical presentations,
skeletal involvement, and therapeutic approaches to hypoparathyroidism led to the …
skeletal involvement, and therapeutic approaches to hypoparathyroidism led to the …
Hyperparathyroidism
JP Bilezikian, L Bandeira, A Khan, NE Cusano - The Lancet, 2018 - thelancet.com
Primary hyperparathyroidism is a common endocrine disorder of calcium metabolism
characterised by hypercalcaemia and elevated or inappropriately normal concentrations of …
characterised by hypercalcaemia and elevated or inappropriately normal concentrations of …
Management of hypoparathyroidism: summary statement and guidelines
…, BL Clarke, RV Thakker, AA Khan… - The Journal of …, 2016 - academic.oup.com
Objective: Hypoparathyroidism is a rare disorder characterized by hypocalcemia and absent
or deficient PTH. This report presents a summary of current information about epidemiology, …
or deficient PTH. This report presents a summary of current information about epidemiology, …
Presentation of hypoparathyroidism: etiologies and clinical features
…, D Dempster, H Dralle, AA Khan… - The Journal of …, 2016 - academic.oup.com
Context: Understanding the etiology, diagnosis, and symptoms of hypoparathyroidism may
help to improve quality of life and long-term disease outcomes. This paper summarizes the …
help to improve quality of life and long-term disease outcomes. This paper summarizes the …
Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial
AA Khan, JP Bilezikian, AWC Kung… - The Journal of …, 2004 - academic.oup.com
Primary hyperparathyroidism (PHPT) is often associated with reduced bone mineral density
(BMD). A randomized, double-blind, placebo-controlled trial was conducted to determine …
(BMD). A randomized, double-blind, placebo-controlled trial was conducted to determine …
Primary hyperparathyroidism
JP Bilezikian, NE Cusano, AA Khan, JM Liu… - Nature reviews Disease …, 2016 - nature.com
Primary hyperparathyroidism (PHPT) is a common disorder in which parathyroid hormone (PTH)
is excessively secreted from one or more of the four parathyroid glands. A single benign …
is excessively secreted from one or more of the four parathyroid glands. A single benign …
Medication-related osteonecrosis of the jaw: MASCC/ISOO/ASCO clinical practice guideline
…, K Bohlke, SL Ruggiero, CA Migliorati, A Khan… - Journal of Clinical …, 2019 - pure.au.dk
PURPOSE To provide guidance regarding best practices in the prevention and management
of medicationrelated osteonecrosis of the jaw (MRONJ) in patients with cancer. METHODS …
of medicationrelated osteonecrosis of the jaw (MRONJ) in patients with cancer. METHODS …